X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2219) 2219
Book Review (433) 433
Publication (125) 125
Conference Proceeding (7) 7
Newsletter (6) 6
Book Chapter (3) 3
Dissertation (3) 3
Magazine Article (3) 3
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1870) 1870
humans (1489) 1489
male (1162) 1162
hypertension (973) 973
losartan (971) 971
female (903) 903
middle aged (749) 749
hypertension - drug therapy (727) 727
losartan intervention (668) 668
end-point reduction (655) 655
aged (633) 633
antihypertensive agents - therapeutic use (623) 623
peripheral vascular disease (575) 575
losartan - therapeutic use (574) 574
animals (492) 492
cardiac & cardiovascular systems (442) 442
blood pressure - drug effects (413) 413
blood-pressure (404) 404
treatment outcome (399) 399
losartan - pharmacology (397) 397
mortality (379) 379
risk factors (370) 370
angiotensin ii type 1 receptor blockers - therapeutic use (340) 340
adult (335) 335
angiotensin (333) 333
hypertension - complications (320) 320
rats (317) 317
hypertension - physiopathology (311) 311
pharmacology & pharmacy (304) 304
blood pressure (294) 294
angiotensin-converting enzyme inhibitors - therapeutic use (273) 273
cardiovascular morbidity (246) 246
drug therapy (242) 242
double-blind method (241) 241
randomized-trial (227) 227
left-ventricular hypertrophy (226) 226
abridged index medicus (225) 225
angiotensin ii type 1 receptor blockers - pharmacology (218) 218
drug therapy, combination (217) 217
angiotensin receptor antagonists (210) 210
medicine, general & internal (198) 198
hypertrophy (193) 193
aged, 80 and over (185) 185
angiotensin ii (185) 185
renin-angiotensin system - drug effects (183) 183
risk (178) 178
diabetes (175) 175
electrocardiography (172) 172
renin-angiotensin system (171) 171
research (171) 171
antihypertensive agents - pharmacology (170) 170
heart-failure (169) 169
heart failure (160) 160
medicine & public health (160) 160
prospective studies (159) 159
left ventricular hypertrophy (158) 158
prevention (158) 158
tetrazoles - therapeutic use (158) 158
urology & nephrology (157) 157
care and treatment (155) 155
losartan - administration & dosage (155) 155
randomized trial (150) 150
time factors (149) 149
valsartan (146) 146
follow-up studies (144) 144
atenolol - therapeutic use (142) 142
hypertrophy, left ventricular - drug therapy (142) 142
stroke (141) 141
analysis (140) 140
hypertrophy, left ventricular - physiopathology (139) 139
cardiology (138) 138
angiotensin-ii (136) 136
atenolol (136) 136
hypertensive patients (136) 136
randomized controlled trials as topic (136) 136
echocardiography (132) 132
cardiovascular disease (130) 130
antihypertensive treatment (128) 128
rats, sprague-dawley (127) 127
disease (126) 126
myocardial-infarction (126) 126
antihypertensive agents - administration & dosage (123) 123
nephropathy (120) 120
prognosis (119) 119
life (118) 118
disease models, animal (116) 116
health aspects (112) 112
dosage and administration (111) 111
outcomes (109) 109
physiology (109) 109
hypertrophy, left ventricular - complications (108) 108
morbidity (107) 107
irbesartan (106) 106
captopril (105) 105
dose-response relationship, drug (105) 105
internal medicine (105) 105
diabetes mellitus, type 2 - complications (104) 104
endocrinology & metabolism (103) 103
mice (103) 103
therapy (103) 103
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2147) 2147
German (23) 23
Spanish (19) 19
Russian (16) 16
French (10) 10
Chinese (7) 7
Norwegian (2) 2
Portuguese (2) 2
Czech (1) 1
Danish (1) 1
Hungarian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 03/2005, Volume 45, Issue 5, pp. 712 - 719
Journal Article
Hypertension, ISSN 0194-911X, 02/2005, Volume 45, Issue 2, pp. 198 - 202
Journal Article
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 03/2002, Volume 359, Issue 9311, pp. 995 - 1003
Blood pressure reduction achieved with β-blockers and diuretics is the best recorded intervention to date for prevention of cardiovascular morbidity and death... 
REGRESSION | OLD PATIENTS | MEDICINE, GENERAL & INTERNAL | EVENTS | CONVERTING-ENZYME-INHIBITOR | MYOCARDIAL-INFARCTION | SWEDISH TRIAL | RISK | ANGIOTENSIN-II | ELECTROCARDIOGRAPHIC IDENTIFICATION | LEFT-VENTRICULAR HYPERTROPHY | Diabetes Complications | Double-Blind Method | Angiotensin Receptor Antagonists | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hypertension - drug therapy | Male | Antihypertensive Agents - therapeutic use | Atenolol - therapeutic use | Losartan - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Aged | Hypertension | Prevention | Evaluation | Heart enlargement | Losartan | Drug therapy | Cardiovascular diseases | Atenolol | Medical research | Cardiovascular disease | Myocardial infarction | Heart | Drugs | Intervention | Heart attacks | Laboratories | Pressure reduction | Blood | Randomization | Electrocardiography | Diuretics | Blood pressure | Angiotensin II | Heart failure | EKG | Edema | Cerebral infarction | Stroke | Mortality | Diabetes mellitus | Health risks | Committees | Uric acid | Regression analysis | Fatal | Angina pectoris | Patients | Morbidity | Angiotensin | Death | Fatalities | Infarction | Ventricle | Diabetes | Health risk assessment | Mercury | Potassium | Hypertrophy | Index Medicus | Abridged Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 04/2009, Volume 119, Issue 14, pp. 1883 - 1891
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 09/2004, Volume 110, Issue 11, pp. 1456 - 1462
Background-An echocardiographic substudy of the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial was designed to test the ability of... 
Hypertension | Echocardiography | Controlled clinical trials | Hypertrophy, left ventricular | Angiotensin | PROGNOSTIC IMPLICATIONS | CARDIAC & CARDIOVASCULAR SYSTEMS | ECHOCARDIOGRAPHIC MEASUREMENTS | METAANALYSIS | controlled clinical trials | echocardiography | hypertrophy, left ventricular | RISK | MORBIDITY | MASS | angiotensin | PERIPHERAL VASCULAR DISEASE | hypertension | SERIAL CHANGES | ASSOCIATION | AMBULATORY BLOOD-PRESSURE | GEOMETRY | Prospective Studies | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Hypertension - drug therapy | Male | Heart Ventricles - diagnostic imaging | Heart Rate - drug effects | Ultrasonography | Aged, 80 and over | Female | Blood Pressure - drug effects | Hypertrophy, Left Ventricular - drug therapy | Heart Ventricles - pathology | Adrenergic beta-Antagonists - therapeutic use | Double-Blind Method | Hypertrophy, Left Ventricular - etiology | Organ Size | Treatment Outcome | Antihypertensive Agents - therapeutic use | Atenolol - therapeutic use | Losartan - therapeutic use | Hypertension - complications | Aged | Heart Ventricles - drug effects | Hypertrophy, Left Ventricular - diagnostic imaging | Index Medicus | Abridged Index Medicus | Antihypertensive Agents/therapeutic use | Angiotensin II Type 1 Receptor Blockers/therapeutic use | Heart Ventricles/drug effects/pathology/ultrasonography | Adrenergic beta-Antagonists/therapeutic use | Hypertrophy; Left Ventricular/drug therapy/etiology/ultrasonography | Blood Pressure/drug effects | Heart Rate/drug effects | Hypertension/complications/drug therapy | Aged; 80 and over | Losartan/therapeutic use | Atenolol/therapeutic use
Journal Article
The Lancet, ISSN 0140-6736, 03/2002, Volume 359, Issue 9311, pp. 1004 - 1010
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2005, Volume 45, Issue 5, pp. 705 - 711
Journal Article
Hypertension, ISSN 0194-911X, 02/2007, Volume 49, Issue 2, pp. 311 - 316
The influence of left atrial size on cardiovascular events during antihypertensive treatment has not been reported previously from a long-term, prospective,... 
Hypertension | Cardiovascular events | Left atrium | Left ventricular hypertrophy | cardiovascular events | M-MODE | GUIDELINES | SYSTEMIC HYPERTENSION | EUROPEAN-SOCIETY | LEFT-VENTRICULAR HYPERTROPHY | ECHOCARDIOGRAPHIC-ASSESSMENT | ATENOLOL | HEART-DISEASE | left ventricular hypertrophy | SOCIETY-OF-CARDIOLOGY | PERIPHERAL VASCULAR DISEASE | left atrium | hypertension | LIFE | Cardiovascular Diseases - etiology | Predictive Value of Tests | Follow-Up Studies | Risk Assessment | Heart Atria | Humans | Hypertrophy, Left Ventricular - etiology | Middle Aged | Hypertension - drug therapy | Male | Antihypertensive Agents - therapeutic use | Incidence | Stroke - etiology | Atenolol - therapeutic use | Echocardiography, Doppler | Losartan - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - mortality | Hypertension - complications | Female | Stroke - epidemiology | Aged | Hypertension - diagnostic imaging | Hypertrophy, Left Ventricular - diagnostic imaging | Index Medicus | Antihypertensive Agents/therapeutic use | Echocardiography; Doppler | Cardiovascular Diseases/etiology/mortality | Hypertension/complications/drug therapy/ultrasonography | Aged; 80 and over | Losartan/therapeutic use | Cerebrovascular Accident/epidemiology/etiology | Hypertrophy; Left Ventricular/etiology/ultrasonography | Atenolol/therapeutic use
Journal Article
JOURNAL OF HYPERTENSION, ISSN 0263-6352, 05/2003, Volume 21, Issue 5, pp. 875 - 886
Background The prognostic benefits of blood pressure lowering treatment in elderly hypertensive patients were established more than a decade ago, but are less... 
cardiovascular events | cognitive function | MORTALITY | LOSARTAN | DEMENTIA | elderly | PREVENTION | BLOOD-PRESSURE | candesartan | STROKE | METABOLISM | MORBIDITY | GLUCOSE | PERIPHERAL VASCULAR DISEASE | hypertension | angiotensin II type 1-receptor blockade
Journal Article
Circulation, ISSN 0009-7322, 08/2003, Volume 108, Issue 6, pp. 684 - 690
Journal Article